It contains no stimulants, no banned compounds, and no artificial additives
Claims involving fat loss, obesity, glucose control, liver disease, sarcopenia, metabolism or anti-ageing could contribute to medicinal classification
While subcutaneous injection remains the gold standard, the modified acetyl and amidated structure may allow for future oral delivery innovations
PubMed For laboratory and research use only
Proposed explanations include: Tissue retention of peptide or active metabolites Persistent activation of signaling cascades beyond peptide clearance Potential for active metabolites with prolonged tissue residence Excretion Pathways Limited data on elimination routes indicates: Likely renal excretion of peptide fragments based on molecular weight and water solubility Potential hepatic contribution to metabolite clearance No evidence of accumulation in chronic dosing studies in rats and monkeys Degradation products eliminated without evidence of toxic metabolite formation The dramatic disconnect between three-minute plasma half-life and prolonged metabolic effects remains one of the most intriguing and poorly understood aspects of AOD-9604 pharmacology, requiring further mechanistic investigation
Modulates growth-factor receptor expression on tendon fibroblasts, including growth-hormone receptor upregulation